Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Hanack

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Antibodies (Basel, Switzerland)|December 22, 2022
SARS-CoV-2 Virus-like Particles (VLPs) Specifically Detect Humoral Immune Reactions in an ELISA-Based PlatformStefan Hirschberg, Hannes Bauer, Julian Kamhieh-Milz, et al.
Journal of Microbiological Methods|December 3, 2014
Identification of whole pathogenic cells by monoclonal antibodies generated against a specific peptide from an immunogenic cell wall proteinHani E J Kaba, Natalia Maier, Nicole Schliebe-Ohler, et al.
Frontiers in Molecular Neuroscience|June 17, 2024
MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive reviewHafiz Muhammad Husnain Azam, Rosa Ilse Rößling, Christiane Geithe, et al.
Journal of Biomolecular Structure & Dynamics|April 9, 2025
Cross-variant immune shield: computational multiepitope vaccine design against B.617.2 to Omicron sub-lineages in SARS-CoV-2Jinal M Thakor, Unnati V Panchal, Dhaval Patel, et al.
Computational and Structural Biotechnology Journal|August 15, 2022
Evaluation of immune evasion in SARS-CoV-2 Delta and Omicron variantsArmi M Chaudhari, Madhvi Joshi, Dinesh Kumar, et al.
Frontiers in Immunology|October 3, 2022
SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applicationsAnja Schlör, Stefan Hirschberg, Ghada Ben Amor, et al.
Arthritis Research & Therapy|May 23, 2016
Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriersDirk Roggenbuck, Maria Orietta Borghi, Valentina Somma, et al.
New Biotechnology|April 11, 2018
Generation and validation of murine monoclonal and camelid recombinant single domain antibodies specific for human pancreatic glycoprotein 2Anja Schlör, Pamela Holzlöhner, Martin Listek, et al.
Vaccines|September 28, 2023
An Efficient and Scalable Method for the Production of Immunogenic SARS-CoV-2 Virus-like Particles (VLP) from a Mammalian Suspension Cell LineStefan Hirschberg, Fatemeh Ghazaani, Ghada Ben Amor, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Antibodies (Basel, Switzerland)|December 22, 2022
SARS-CoV-2 Virus-like Particles (VLPs) Specifically Detect Humoral Immune Reactions in an ELISA-Based PlatformStefan Hirschberg, Hannes Bauer, Julian Kamhieh-Milz, et al.
Journal of Microbiological Methods|December 3, 2014
Identification of whole pathogenic cells by monoclonal antibodies generated against a specific peptide from an immunogenic cell wall proteinHani E J Kaba, Natalia Maier, Nicole Schliebe-Ohler, et al.
Frontiers in Molecular Neuroscience|June 17, 2024
MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive reviewHafiz Muhammad Husnain Azam, Rosa Ilse Rößling, Christiane Geithe, et al.
Journal of Biomolecular Structure & Dynamics|April 9, 2025
Cross-variant immune shield: computational multiepitope vaccine design against B.617.2 to Omicron sub-lineages in SARS-CoV-2Jinal M Thakor, Unnati V Panchal, Dhaval Patel, et al.
Computational and Structural Biotechnology Journal|August 15, 2022
Evaluation of immune evasion in SARS-CoV-2 Delta and Omicron variantsArmi M Chaudhari, Madhvi Joshi, Dinesh Kumar, et al.
Frontiers in Immunology|October 3, 2022
SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applicationsAnja Schlör, Stefan Hirschberg, Ghada Ben Amor, et al.
Arthritis Research & Therapy|May 23, 2016
Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriersDirk Roggenbuck, Maria Orietta Borghi, Valentina Somma, et al.
New Biotechnology|April 11, 2018
Generation and validation of murine monoclonal and camelid recombinant single domain antibodies specific for human pancreatic glycoprotein 2Anja Schlör, Pamela Holzlöhner, Martin Listek, et al.
Vaccines|September 28, 2023
An Efficient and Scalable Method for the Production of Immunogenic SARS-CoV-2 Virus-like Particles (VLP) from a Mammalian Suspension Cell LineStefan Hirschberg, Fatemeh Ghazaani, Ghada Ben Amor, et al.
Pageof 3